University at Buffalo - The State University of New York
Skip to Content

News

James D. Bangs, PhD
2/27/17

James D. Bangs, PhD, Grant T. Fisher Professor and chair of microbiology and immunology, has received National Institutes of Health (NIH) funding to continue his study of human African trypanosomiasis, also known as sleeping sickness.

Rajendram Rajnarayanan, PhD, Anthony Jones and Margarita Dubocovich
1/31/17

Anthony J. Jones, a doctoral student in the neuroscience program, has received a two-year fellowship award in pharmacology/toxicology from the PhRMA Foundation.

Anthony A. Campagnari, PhD, ’84
6/6/16

Anthony A. Campagnari, PhD ’84, senior associate dean for research and graduate education, has received the 2016 Stockton Kimball Award for outstanding scientific achievement and service.

Jun-Xu Li, MD, PhD and pharmacology graduate students and trainees.
3/28/16

Graduate student and trainee researchers and their mentors in the Department of Pharmacology and Toxicology received positive feedback on in-depth studies they presented at the 2016 Behavior, Biology and Chemistry: Translational Research in Addiction meeting.

Meaghan Paganelli, PhD, and Gabriela Popescu, PhD
6/3/15
Two expert reviewers for the global literature review service F1000Prime have recommended a University at Buffalo paper identifying molecular mechanisms affected by the local anesthetic bupivacaine.
Anthony A. Campagnari, PhD
4/6/15

The Graduate School has recognized Anthony A. Campagnari, PhD ’84, professor of microbiology and immunology and medicine, with an Excellence in Graduate Student Mentoring Award.

Fraser J. Sim, PhD
3/6/15
University at Buffalo researchers are the first to identify solifenacin as a drug target to promote stem cell therapy for myelin-based disease, such as multiple sclerosis.
Jonathan F. Lovell, PhD
1/26/15

An international team led by Jonathan F. Lovell, PhD, assistant professor of biomedical engineering, has created a nanoparticle that may pave the way for “hypermodal” imaging — the ability to merge results from six different imaging modes using one contrast agent.

Ulas Sunar, PhD
1/22/15
University at Buffalo researchers have designed a biomedical device that could make chemotherapy more efficient, reduce its side effects and improve how doctors treat some of the most deadly forms of cancer.
Jennifer A. Surtees, PhD
1/9/15

With the goal of improving chemotherapy, Jennifer A. Surtees, PhD, associate professor of biochemistry, will study what makes cancer cells sensitive or resistant to different DNA-damaging drugs.

Frederick Sachs, PhD
1/9/15
Using mechanical stress, scientists at the University at Buffalo and colleagues have turned normal cells into ‘stem-like’ cells, suggesting a possible safe, new way to produce stem cells.
Anthony L. Auerbach, PhD
1/9/15
University at Buffalo research on acetylcholine receptors (AChR) will help pharmacologists better understand how drugs work and could help make “receptor engineering” a reality.
Bogdan K. Beirowski, MD, PhD
12/15/14
A University at Buffalo biochemist led the first study to identify the liver kinase B1 (LKB1) pathway as a possible therapeutic target for neuropathies, including diabetic neuropathy.
Frederick Sachs, PhD
10/20/14
A drug developed by University at Buffalo scientists from a small protein found in spider venom is moving forward as a promising treatment for Duchenne muscular dystrophy, a fatal genetic disease affecting boys.